Latest news with #Runtz
Yahoo
12-06-2025
- Business
- Yahoo
Method Man's TICAL Partners with European E-Commerce Giant Zamnesia for Exclusive Cannabis Seed Launch
Premium Cannabis Seeds from Hip-Hop Legend Now Available Exclusively Through Zamnesia's Global Platform WEAVERVILLE, N.C., June 12, 2025--(BUSINESS WIRE)--Zamnesia, Europe's leading online Smartshop and established U.S. online retailer, has kicked off an exclusive partnership with TICAL, the cannabis brand founded by hip-hop legend Method Man. This collaboration spotlights eight premium cannabis seeds in the U.S. and in Europe, exclusively through Zamnesia. The TICAL x Zamnesia partnership spotlights Method Man's iconic 'Killa Bee' symbolism by embracing a lifestyle that spurs creativity, inclusivity, and a deep connection to the natural world. The shared "We Bring the Buzz," program inspires an authentic, vibrant, and profoundly meaningful movement for the cannabis community. "TICAL and Zamnesia are a natural fit. We're united by a foundation of authenticity and deep roots in the cannabis culture," said Nick Avé, General Manager at Zamnesia. "Both Method Man and Zamnesia are regarded as OGs in the cannabis scene and we bring decades of experience, respect and influence to the table." The exclusive seed drop features eight premium strains personally selected and approved by Method Man, including: Shaolin Spritzer (Runtz x Mac x Blue Dream) — THC: 20%-23% Method Mac (Alien Cookies x (Colombian x Starfighter)) — THC: 21%-25% Sweet Morning Mimosa (Clementine x Purple Punch) — THC: 21%-24% 24K Gold Fangs (Kosher Kush x Tangie) — THC: 22%-26% Spazzola Garletti (Chem D x Gelato) — THC: 22%-26% Grape Gorilla Gas (Grape Ape x Gas Mask) —THC: 23%-25% La-La-La Log Cabin (Pineapple x Cookies) — THC: 20%-24% Rugged Runtz (Zkittlez x Gelato) — THC: 20%-25% "I don't put my name on just anything. These TICAL seeds? Handpicked, perfected, and ready to rep real flavor across borders. Big love to Zamnesia…for showing up and showing love," said Method Man. The campaign will leverage both Method Man's official channels and Zamnesia's global network of over 350,000 cannabis customers, combining celebrity influence with established expertise in cannabis seeds and home cultivation. "This collaboration is about more than just business—it's a celebration of a way of life," added Avé. "Together, Zamnesia and TICAL came together to honor the spirit and energy of our combined voices, sharing the passion, love and innovation that fuels the cannabis and hip-hop lifestyles." Beyond the cultural roots and pioneering presence, Zamnesia and TICAL are innovators that bring artistry to life through unique packaging, limited-edition collab strains and engaging, international campaigns that inspire communities across continents. This summer, TICAL and Zamnesia will drop an ultra-limited collab strain designed specifically for the OGs who've built the culture from the ground up. With unique genetics, exclusive collector's packaging, and a once-in-a-lifetime drop format, this highly anticipated release will ignite serious buzz on both sides of the Atlantic. U.S. cannabis enthusiasts can explore and purchase the exclusive TICAL strains at About Zamnesia Established in 2012, Zamnesia is Europe's go-to e-commerce shop for cannabis-related items and mind-enhancing products. Now serving the U.S. market, Zamnesia operates with the highest level of professionalism, reliability and service with over one million customers served. Its culture is based on teamwork and passion for cannabis and mushrooms, and a mission to make world-class natural products accessible to everyone. Zamnesia's team of experts in cannabis, mushroom cultivation techniques and endogenous substances keeps a close eye on emerging trends. Discover Zamnesia's comprehensive assortment of the best Mother Nature has to offer at About TICAL TICAL is a premium cannabis brand founded by hip-hop legend Method Man, offering high-quality cannabis products that reflect his decades of experience and passion for the plant. Named after his 1994 solo debut album, TICAL (Taking Into Consideration All Lives) embodies Method Man's commitment to authenticity, quality, and respect for cannabis culture. Learn more: View source version on Contacts Media Contact: Casey EcholsGrasslands: A Journalism-Minded Agencycaseyechols@
Yahoo
11-06-2025
- Health
- Yahoo
Several marijuana products recalled in New York State
ALBANY, N.Y. (WIVT/WBGH) — New York State's Office of Cannabis Management has issued a recall on several cannabis products due to public health concerns. Multiple adult-use cannabis products produced by IndoGrow have been recalled. The regulated products are being sold through licensed cannabis dispensaries throughout New York State. According to the Office, the affected products were originally quarantined due to a lack of validity in testing by a former permitted laboratory. The Office authorized a re-test of the products, and nine lots failed due to the presence of unallowable pesticides, posing a potential risk to public health and safety. The following products are affected: The Force Pre-Roll Blue Coffee Flower Blue Coffee Pre-Roll Sour Runtz Flower Sour Runts Pre-Roll Cosmic Burst Flower Oreoz Flower Oreoz Pre-Roll Secret Formula Flower Dispensaries and distributors must cease distribution and sales of the above products immediately. The products may also go by names such as Indi, Grow by Indi, Our Creation, and Grow withUs. The Office of Cannabis Management reminds consumers to report any incidents related to the use of these products or any other cannabis product by completing an incident here. Binghamton Firefighters say 'farewell' to another brother Local eateries face off in Chef Show Down at Kilmer Mansion Pizza Week 2025: Vestal Bakery Law Enforcement Torch Run raises money for Special Olympics SRO Productions presents 'A New Brain' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Associated Press
25-04-2025
- Associated Press
Illegal Out-of-State Cannabis Products Discovered for Sale in Licensed New York Dispensaries, Undercutting Local Equity Operators, Farmers & Processors
NEW YORK--(BUSINESS WIRE)--Apr 25, 2025-- An alarming new investigation released by members of the New York Medical Cannabis Industry Association has uncovered that illegal cannabis flower - smuggled in from the West Coast - is being sold in licensed dispensaries across New York State. Lab-verified findings confirm that at least two widely available brands, Heady Tree and Runtz, were not grown in New York and entered the state illegally. Bulk quantities of out-of-state products easily made their way into New York and on to the shelves of legal stores because New York regulators have not implemented a track-and-trace system. Advanced testing from a fully accredited Office of Cannabis Management lab in conjunction with academic partners analyzed the cannabis flower to identify pesticides, soil type, and metals and determined with high probability that the cannabis from these brands was grown on the West Coast. Findings can be found here. Additional testing is ongoing to verify other brands suspected of nefarious activities. While cannabis is legal in a growing number of states, it is still illegal federally, meaning that cannabis cannot be distributed across state lines. All cannabis sold in New York must be grown and processed within the state's borders - a regulation designed to support local farmers, protect public health, and ensure legal tested, products generate tax revenue that benefits all New Yorkers. 'Even one product from out of state ending up on a licensed dispensary shelf is unacceptable,' said Ngiste Abebe, spokesperson for the New York Medical Cannabis Industry Association. 'The fact that multiple brands were found at multiple stores shows we have a systemic failure. The lack of a standardized track-and-trace system is directly enabling this problem. The Office of Cannabis Management has had over two years since adult-use sales began, but we still don't have BioTrack fully implemented. That's inexcusable, and its hurting compliant businesses most of all.' This growing problem - known as 'inversion' - occurs when cannabis grown in oversaturated markets like California, Oregon, and Washington is illegally diverted into newer markets like New York where cannabis processors and distributors purchase it for heavily discounted prices. It undermines the integrity of New York's regulated cannabis system, robs compliant businesses of shelf space and sales, and cheats the state out of vital tax dollars. To stop inversion, the OCM must immediately implement and enforce the BioTrack seed-to-sale tracking system, a system selected by NY State, to safeguard the legal market, protect consumers, and support licensed New York operators. Transcripts from a February 2023 OCM Control Board Meeting discuss the anticipated availability of BioTrack in March 2023 with a 60-day implementation period. Nearly two years later, BioTrack is still not in place. Without the urgent implementation of BioTrack, the illicit market will continue to grow inside the very system designed to replace it. Every day that the illicit market is allowed to grow has devastating consequences for the whole cannabis industry. The illicit market is actively harming cannabis sales which slows down the opening of new dispensaries and the diversification of legal products, stalls job growth, and harms patients in New York by curbing growth of the medical market. The chief priority of the OCM should be implementing BioTrack to stop illegal cannabis from making its way into New York. About The New York Medical Cannabis Industry Association (NYMCIA) The New York Medical Cannabis Industry Association is comprised of Columbia Care, Cresco, Curaleaf, Green Thumb Industries, The Botanist and Acreage NY, iAnthus, and Pharmacann. Our mission is to protect and serve the patients in New York's medical marijuana program while leading the way for the adult-use industry across the state. Learn more about NYMCIA at View source version on Media Contact: Samantha [email protected] KEYWORD: UNITED STATES NORTH AMERICA NEW YORK INDUSTRY KEYWORD: SUPPLY CHAIN MANAGEMENT CANNABIS SPECIALTY LAW ENFORCEMENT/EMERGENCY SERVICES WHITE HOUSE/FEDERAL GOVERNMENT AGRICULTURE STATE/LOCAL NATURAL RESOURCES PUBLIC POLICY OTHER POLICY ISSUES ADVOCACY GROUP OPINION RETAIL PUBLIC POLICY/GOVERNMENT SOURCE: New York Medical Cannabis Industry Association (NYMCIA) Copyright Business Wire 2025. PUB: 04/25/2025 12:38 PM/DISC: 04/25/2025 12:38 PM
Business Wire
25-04-2025
- Business Wire
Illegal Out-of-State Cannabis Products Discovered for Sale in Licensed New York Dispensaries, Undercutting Local Equity Operators, Farmers & Processors
NEW YORK--(BUSINESS WIRE)--An alarming new investigation released by members of the New York Medical Cannabis Industry Association has uncovered that illegal cannabis flower - smuggled in from the West Coast - is being sold in licensed dispensaries across New York State. Lab-verified findings confirm that at least two widely available brands, Heady Tree and Runtz, were not grown in New York and entered the state illegally. Bulk quantities of out-of-state products easily made their way into New York and on to the shelves of legal stores because New York regulators have not implemented a track-and-trace system. Advanced testing from a fully accredited Office of Cannabis Management lab in conjunction with academic partners analyzed the cannabis flower to identify pesticides, soil type, and metals and determined with high probability that the cannabis from these brands was grown on the West Coast. Findings can be found here. Additional testing is ongoing to verify other brands suspected of nefarious activities. While cannabis is legal in a growing number of states, it is still illegal federally, meaning that cannabis cannot be distributed across state lines. All cannabis sold in New York must be grown and processed within the state's borders - a regulation designed to support local farmers, protect public health, and ensure legal tested, products generate tax revenue that benefits all New Yorkers. 'Even one product from out of state ending up on a licensed dispensary shelf is unacceptable,' said Ngiste Abebe, spokesperson for the New York Medical Cannabis Industry Association. 'The fact that multiple brands were found at multiple stores shows we have a systemic failure. The lack of a standardized track-and-trace system is directly enabling this problem. The Office of Cannabis Management has had over two years since adult-use sales began, but we still don't have BioTrack fully implemented. That's inexcusable, and its hurting compliant businesses most of all.' This growing problem - known as 'inversion' - occurs when cannabis grown in oversaturated markets like California, Oregon, and Washington is illegally diverted into newer markets like New York where cannabis processors and distributors purchase it for heavily discounted prices. It undermines the integrity of New York's regulated cannabis system, robs compliant businesses of shelf space and sales, and cheats the state out of vital tax dollars. To stop inversion, the OCM must immediately implement and enforce the BioTrack seed-to-sale tracking system, a system selected by NY State, to safeguard the legal market, protect consumers, and support licensed New York operators. Transcripts from a February 2023 OCM Control Board Meeting discuss the anticipated availability of BioTrack in March 2023 with a 60-day implementation period. Nearly two years later, BioTrack is still not in place. Without the urgent implementation of BioTrack, the illicit market will continue to grow inside the very system designed to replace it. Every day that the illicit market is allowed to grow has devastating consequences for the whole cannabis industry. The illicit market is actively harming cannabis sales which slows down the opening of new dispensaries and the diversification of legal products, stalls job growth, and harms patients in New York by curbing growth of the medical market. The chief priority of the OCM should be implementing BioTrack to stop illegal cannabis from making its way into New York. The New York Medical Cannabis Industry Association is comprised of Columbia Care, Cresco, Curaleaf, Green Thumb Industries, The Botanist and Acreage NY, iAnthus, and Pharmacann. Our mission is to protect and serve the patients in New York's medical marijuana program while leading the way for the adult-use industry across the state. Learn more about NYMCIA at
